Approval · Notice of Compliance 20201 · 2017
AMINOSYN: Notice of Compliance 20201
Issued December 22, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20201
- Date
- December 22, 2017
- Company
- Icu Medical Canada IncRichmond Hill, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Administrative - Merger/Buyout Brand Name Change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AMINOSYN | 00454907 | Cancelled Post Market |
Medicinal ingredients
- ALANINE 12.8 MG per ML
- ARGININE 9.8 MG per ML
- GLYCINE 12.8 MG per ML
- HISTIDINE 3 MG per ML
- ISOLEUCINE 7.2 MG per ML
- LYSINE 7.2 MG per ML
- LEUCINE 9.4 MG per ML
- METHIONINE 4 MG per ML
- PHENYLALANINE 4.4 MG per ML
- PROLINE 8.6 MG per ML
- SERINE 4.2 MG per ML
- THREONINE 5.2 MG per ML
- TRYPTOPHAN 1.6 MG per ML
- TYROSINE 0.44 MG per ML
- VALINE 8 MG per ML